Kara P Wiseman1, Diane L Bishop, Qin Shen, Resa M Jones. 1. Division of Epidemiology, Department of Family Medicine and Population Health, School of Medicine, Virginia Commonwealth University, 830 E. Main St., 8th Floor, P.O. Box 980212, Richmond, VA, 23298-0212, USA.
Abstract
PURPOSE: The study purpose is to describe who breast cancer survivors see for their care by years since diagnosis and determine the association between time since diagnosis and the type of clinician providing the majority of care, taking into account receipt of follow-up care instructions. METHODS: The 2010 Behavioral Risk Factor Surveillance System was used to identify a sample (N = 1024) of women with a self-reported history of breast cancer. Descriptive characteristics were calculated and stratified by years since diagnosis. Multivariate logistic regression adjusting for age, income, and receiving follow-up care instructions was performed to evaluate the association between years since diagnosis and clinician providing the majority of care. RESULTS: The type of clinician reported most frequently was a primary care provider. Women 0-1 year since diagnosis had the highest proportion reporting a cancer-related clinician for their care. After adjustment, women 0-1, 2-3, and 4-5 years since diagnosis were respectively 2.1, 2.6, and 1.7 times more likely to have a cancer-related clinician providing the majority of care compared to women 6+ years since diagnosis (respective 95 % confidence intervals (CIs) 1.0-4.3; 1.4-4.6; 0.9-3.1). CONCLUSIONS: Breast cancer survivors receive the majority of their care from primary care providers, and years since diagnosis has a significant impact on who survivors see for their care. Breast cancer survivors have nationally recommended follow-up guidelines; however, the type of clinician that should provide care is not specified. Information regarding who provides the majority of care can be used for future planning and policy development.
PURPOSE: The study purpose is to describe who breast cancer survivors see for their care by years since diagnosis and determine the association between time since diagnosis and the type of clinician providing the majority of care, taking into account receipt of follow-up care instructions. METHODS: The 2010 Behavioral Risk Factor Surveillance System was used to identify a sample (N = 1024) of women with a self-reported history of breast cancer. Descriptive characteristics were calculated and stratified by years since diagnosis. Multivariate logistic regression adjusting for age, income, and receiving follow-up care instructions was performed to evaluate the association between years since diagnosis and clinician providing the majority of care. RESULTS: The type of clinician reported most frequently was a primary care provider. Women 0-1 year since diagnosis had the highest proportion reporting a cancer-related clinician for their care. After adjustment, women 0-1, 2-3, and 4-5 years since diagnosis were respectively 2.1, 2.6, and 1.7 times more likely to have a cancer-related clinician providing the majority of care compared to women 6+ years since diagnosis (respective 95 % confidence intervals (CIs) 1.0-4.3; 1.4-4.6; 0.9-3.1). CONCLUSIONS:Breast cancer survivors receive the majority of their care from primary care providers, and years since diagnosis has a significant impact on who survivors see for their care. Breast cancer survivors have nationally recommended follow-up guidelines; however, the type of clinician that should provide care is not specified. Information regarding who provides the majority of care can be used for future planning and policy development.
Authors: Ruth A Lewis; Richard D Neal; Nefyn H Williams; Barbara France; Maggie Hendry; Daphne Russell; Dyfrig A Hughes; Ian Russell; Nicholas S A Stuart; David Weller; Clare Wilkinson Journal: Br J Gen Pract Date: 2009-07 Impact factor: 5.386
Authors: Kevin C Oeffinger; Keith E Argenbright; Gill A Levitt; Mary S McCabe; Paula R Anderson; Emily Berry; Jane Maher; Janette Merrill; Dana S Wollins Journal: Am Soc Clin Oncol Educ Book Date: 2014
Authors: Christopher R Friese; Kathryn A Martinez; Paul Abrahamse; Ann S Hamilton; John J Graff; Reshma Jagsi; Jennifer J Griggs; Sarah T Hawley; Steven J Katz Journal: Breast Cancer Res Treat Date: 2014-01-31 Impact factor: 4.872
Authors: James L Khatcheressian; Antonio C Wolff; Thomas J Smith; Eva Grunfeld; Hyman B Muss; Victor G Vogel; Francine Halberg; Mark R Somerfield; Nancy E Davidson Journal: J Clin Oncol Date: 2006-10-10 Impact factor: 44.544
Authors: Jeanne S Mandelblatt; William F Lawrence; Jennifer Cullen; Annette L Stanton; Janice L Krupnick; Lorna Kwan; Patricia A Ganz Journal: J Clin Oncol Date: 2006-01-01 Impact factor: 44.544
Authors: Arnold L Potosky; Paul K J Han; Julia Rowland; Carrie N Klabunde; Tenbroeck Smith; Noreen Aziz; Craig Earle; John Z Ayanian; Patricia A Ganz; Michael Stefanek Journal: J Gen Intern Med Date: 2011-07-22 Impact factor: 5.128
Authors: Carriene Roorda; Geertruida H de Bock; Christian Scholing; Klaas van der Meer; Marjolein Y Berger; Marlieke de Fouw; Annette J Berendsen Journal: Health Expect Date: 2014-03-25 Impact factor: 3.377
Authors: Anna Jansana; Margarita Posso; Inmaculada Guerrero; Alexandra Prados-Torres; Maria Isabel Del Cura; Xavier Castells; Maria Sala Journal: J Cancer Surviv Date: 2019-04-09 Impact factor: 4.442
Authors: Brynn Fowler; Qian Ding; Lisa Pappas; Yelena P Wu; Lauri Linder; Jeff Yancey; Jennifer Wright; Margaret Clayton; Deanna Kepka; Anne C Kirchhoff Journal: J Cancer Educ Date: 2018-02 Impact factor: 2.037
Authors: K Enright; T Desai; R Sutradhar; A Gonzalez; M Powis; N Taback; C M Booth; M E Trudeau; M K Krzyzanowska Journal: Curr Oncol Date: 2018-04-30 Impact factor: 3.677